PAA 2.56% 20.0¢ pharmaust limited

PAA Speech at Med Tech & Healthcare Investors Night July 2019, page-48

  1. 434 Posts.
    lightbulb Created with Sketch. 120
    Agreed @Lfc786 all a bit of fun banter though.

    I think its fair to say they have already commenced promotion/marketing given the investor presentation lodged on ASX and the recent media attention from Australian and US based sources.This is backed up by the increase in volume and price of the shares. I would predict an increase of marketing as we head into the phase 2 cane trials.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.